Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Benzeno Sharon sold 165,802 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Jun 26 to Jun 29, 2026 · Filed Jun 30, 2026
From Jun 26 to Jun 29, 2026, Benzeno Sharon (Chief Commercial Ofc Imm Med) sold 165,802 Adaptive Biotechnologies Corporation shares at an average US$21.13 for US$3.5M under a trading plan, leaving 221,278 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 165,802 shares
- Price
- US$21.13 average (US$21.00 to US$21.14)
- Value
- US$3.5M
- Holding after
- 221,278 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Ofc Imm Med
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Option exercise | 11,034 | US$12.14 | 283,785 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 11,034 | US$21.00 | 272,751 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 1,837 | US$12.14 | 274,588 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 24,944 | US$8.46 | 299,532 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 24,944 | US$3.99 | 324,476 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 51,570 | US$8.12 | 376,046 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 154,768 | US$21.14 | 221,278 | Direct |